Press Releases
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2022
August 3, 2022
Morphic to Present at 2022 Jefferies Global Healthcare Conference
June 9, 2022
Morphic Appoints Joanne Gibbons as Senior Vice President of Regulatory Affairs
May 18, 2022
Morphic Announces Participation in 2022 RBC Capital Markets Global Healthcare Conference
May 17, 2022
Morphic Names Bruce Rogers as President of Morphic Therapeutic and Blaise Lippa as Chief Scientific Officer
May 12, 2022
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022
May 4, 2022
Morphic Therapeutic Expands Leadership with Key Appointments in Clinical and Corporate Development
April 6, 2022
Morphic to Participate in BMO Inflammation and Immunology Spotlight Series Panel
March 30, 2022
Morphic Therapeutic Announces Initiation of EMERALD-1 Phase 2a Clinical Trial of MORF-057 in Patients with Ulcerative Colitis
March 25, 2022
Morphic Announces Participation In Cowen 42nd Annual Healthcare Conference
March 4, 2022
Displaying 1 - 10 of 13